Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison

scientific article published on July 1999

Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/JCP.52.7.498
P932PMC publication ID501489
P698PubMed publication ID10605401
P5875ResearchGate publication ID246200515

P50authorChris J L M MeijerQ90379336
Peter J F SnijdersQ90768556
P2093author name stringMeyer T
Dillner J
Wadell G
Strand A
Johansson B
von Knebel Doeberitz M
Pfister H
Stockfleth E
Walboomers JM
Forslund O
Jacobs MV
Nindl I
Voorhorst FJ
P2860cites workAccuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.Q30452566
Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reactionQ36081505
Intermethod variation in detection of human papillomavirus DNA in cervical smearsQ36525380
A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapingsQ36543787
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.Q36544266
Comparison of dot filter hybridization, Southern transfer hybridization, and polymerase chain reaction amplification for diagnosis of anal human papillomavirus infection.Q37084174
An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopyQ38467122
Detection and typing of human papillomaviruses present in fixed and stained archival cervical smears by a consensus polymerase chain reaction and direct sequence analysis allow the identification of a broad spectrum of human papillomavirus typesQ38486887
The Papanicolaou test for cervical cancer detection. A triumph and a tragedyQ38597626
The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypesQ39101956
Human papillomavirus testing in primary cervical screening.Q52338437
Risk Factors for Cervical Cancer in Thailand: a Case-Control StudyQ58296906
A normal cervical smear and yet cervical cancerQ67961540
Recent trends in cervix uteri cancerQ69777166
Interlaboratory agreement in a polymerase chain reaction-based human papillomavirus DNA assayQ71469889
A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+ PCRQ71562461
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significanceQ72636618
The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCRQ73108013
Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical scrapesQ77392078
P4510describes a project that usespolymerase chain reactionQ176996
P433issue7
P407language of work or nameEnglishQ1860
P304page(s)498-503
P577publication date1999-07-01
P1433published inJournal of Clinical PathologyQ6294965
P1476titleReliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison
P478volume52

Reverse relations

cites work (P2860)
Q54573717CHAPTER 7 Methods for detection of HPV infection and its clinical utility.
Q77836045Cervical cancer
Q33893044Cervical cytology after 2000: where to go?
Q36584410Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases
Q35587773Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology.
Q35073445Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program
Q36857709Detection and typing of human papilloma virus by multiplex PCR with type-specific primers.
Q82735911ELISA test to detect CDKN2A (p16(INK4a)) expression in exfoliative cells: a new screening tool for cervical cancer
Q53519290Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma.
Q33488325Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model
Q34492018Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia
Q37461977Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Q34466134HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis
Q36645480HPV Population Profiling in Healthy Men by Next-Generation Deep Sequencing Coupled with HPV-QUEST.
Q34390791High-resolution melting molecular signatures for rapid identification of human papillomavirus genotypes
Q81404025Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
Q44751201Human papillomavirus detection and typing using a nested-PCR-RFLP assay
Q40023480Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia
Q34305225Immunity to oncogenic human papillomaviruses
Q81102317Immunocytochemical staining of p16(ink4a) protein as an adjunct test in equivocal liquid-based cytology
Q80796966Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection
Q33290324Inter-laboratory validation of PCR-based HPV detection in pathology specimens
Q34773451International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement
Q33181477Intra-laboratory reproducibility of human papillomavirus identification in cervical specimens by a polymerase chain reaction-based assay
Q37503427Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.
Q39189708Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial
Q42204957Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.
Q33973389Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples
Q47345483Oncogenic viruses in Skull Base Chordomas
Q37291430Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries
Q36121308Prevalence of human papillomavirus in university young women
Q34074998Recent advances in diagnosis and therapy of human papillomaviruses
Q92256596The potential of RNA as a target for national screening of pre-cancer
Q34089060Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection
Q54763506Type-specific detection of human papillomaviruses in a routine laboratory setting--improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation.
Q47732272Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Q35586592p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.

Search more.